(Q82568571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Maisoun Abdelbaqi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

John H Chidlow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Kametra M Matthews

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Kevin P Pavlick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shayne C Barlow

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Andrea J Linscott

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Matthew B Grisham

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marjorie R Fowler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

380-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482101%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.3700398

16 January 2020

exact match

0 references

cites work

Host-bacterial interactions in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Immunomodulatory therapy for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Severe inflammatory bowel disease: medical management

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Inflammatory bowel disease: new insights into pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

The pathogenesis of inflammatory bowel disease: translational implications for clinicians.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Endoscopy in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Inflammatory bowel disease: pathogenesis and targets for therapeutic interventions.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

CD18 deficiency protects against multiple low-dose streptozotocin-induced diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Psoriasiform dermatitis susceptibility in Itgb2(tm1Bay) PL/J mice requires low-level CD18 expression and at least two additional loci for progression to severe disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Severe inflammatory defect and reduced viability in CD18 and E-selectin double-mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

The leukocyte integrins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Endothelial cell activation in inflammation: lessons from mutant mouse models.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Manifestations of inflammatory arthritis are critically dependent on LFA-1

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Experimental models of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Experimental Models to Study Molecular Mechanisms Underlying Intestinal Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Mouse models for the study of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Protection of the intestinal mucosa by intraepithelial gamma delta T cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Anti-neutrophil serum attenuates dextran sulfate sodium-induced colonic damage in the rat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Role of gamma delta T cells in the inflammatory response of experimental colitis mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Spontaneous skin ulceration and defective T cell function in CD18 null mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Role of cell adhesion molecules in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in acute and chronic inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Alteration in expression of beta 2 integrins on lamina propria lymphocytes in ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Beta2 integrin/ICAM expression in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Peripheral blood lymphocyte beta 2 integrin and ICAM expression in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

LFA-1 subunit expression in ulcerative colitis patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

A novel gene delivery system targeting cells expressing VEGF receptors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

The differential roles of LFA-1 and Mac-1 in host defense against systemic infection with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Bacterial load in animal models of acute and chronic 'reactivated' colitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Increased lymphocyte trafficking to colonic microvessels is dependent on MAdCAM-1 and C-C chemokine mLARC/CCL20 in DSS-induced mice colitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Severe and steroid-resistant Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Efalizumab: continuous therapy for chronic psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Alpha L-integrin I domain cyclic peptide antagonist selectively inhibits T cell adhesion to pancreatic islet microvascular endothelium.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by x-ray analysis and monitoring of LFA-1 conformational changes in vitro and ex vivo

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021

Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700398

7 January 2021